Pantoprazole and Ranitidine in the Treatment of Acute Duodenal Ulcer: A Multicentre Study

References

• Simon W. A., Keeling D. J., Laing S. M., Fallowfield C., Taylor A. G. BY1023/SK&F96022: biochemistry of a novel (H++ K+)-ATPase inhibitor. Biochem Pharmacol 1990; 39: 1799–806
   PubMed Web of Science ®Google Scholar
• Shin J. M., Besancon M., Simon A., Sachs G. The site of action of pantoprazole in the gastric H+/K+-ATPase. Biochim Biophys Acta 1993; 1148: 223–33
   PubMed Web of Science ®Google Scholar
• Simon B., Müller P, Marinis E, Lühmann R, Huber R, Hartmann M, et al. Effect of repeated oral administration of BY1023/SK&F96022—a new substituted benzimidazole derivative-on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990; 4: 373–9
   PubMed Web of Science ®Google Scholar
• Simon B., Müller P, Hartmann M, Bliesath H, Lühmann R, Huber R, et al. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+K+-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers. Z Gastroenterol 1990; 28: 443–7
   PubMed Web of Science ®Google Scholar
• Simon W. A., Büdingen C, Fahr S, Kinder B, Koske M. The H+K+-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochem Pharmacol 1991; 42: 347–55
   PubMed Web of Science ®Google Scholar
• Müller F. O., Middle M. V., Duursema L., Hundt HKL, Swart K. J., Schall R., et al. Pantoprazole does not affect the pharmacodynamics and pharmacokinetics of warfarin in healthy males. Klin Pharmakol Aktuell 1993; 2: 40
   Google Scholar
• Schulz H-U, Hartmann M, Steinijans V. W., Huber R., Lührmann B, Bliesath H, et al. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man. Int J Clin Pharmacol Ther Toxicol 1991; 29: 369–75
   PubMedGoogle Scholar
• Gugler R., Hartmann M., Rudi J., Bliesath H., Brod I., Klotz V., et al. Lack of interaction of pantoprazole and diazepam in man. Gastroenterology 1992; 102: A77
   Google Scholar
• Müller F. O., Bliesath H., Middle M. V., Hundt HKL, Hartmann M, Schall R, et al. Pantoprazole does not influence the pharmacokinetics of phenytoin in man. Klin Pharmakol Aktuell 1993; 2: 26
   Google Scholar
• Middle M. V., Müller F. O., Mogilnicka E. M., Hundt HKL, Beneke P. C., Schall R., et al. Pantoprazole does not influence ovulation suppression by a low-dose hormonal contraceptive. Klin Pharmakol Aktuell 1993; 2: 40
   Google Scholar
• Reill L., Erhardt F., Fischer R., Londong W. Intragastric pH and serum gastrin after one week treatment with pantoprazole, ranitidine or placebo in man. Gastroenterology 1993; 104: A177
   Web of Science ®Google Scholar
• Hartmann M., Bliesath H., Kuhn I., Lühmann R, Huber R, Wurst W, et al. 24 h intragastric pH following oral intake of pantoprazole and omeprazole. Hellenic J Gastroenterol 1992; 5 Suppl: 112
   Google Scholar
• Müller P, Simon B, Khalil K, Lühmann R, Leucht U, Schneider A. Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Z Gastroenterol 1992; 30: 771–5
   PubMed Web of Science ®Google Scholar
• Reill L., Erhardt F., Fischer R., Huber R., Londong W. Dose-response of pantoprazole 20, 40 and 80 mg on 24-hour intragastric pH and serum gastrin in man. Gut 1993; 34 Suppl: S63
   Google Scholar
• McIsaac R. L., Dixon J. S., Mills J. G., Wood J. R. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate. Aliment Pharmacol Ther 1991; 5: 227–43
   PubMed Web of Science ®Google Scholar
• McFarland R. J., Bateson M. C., Green JRB, O'Donoghue D. P., Dronfield M. W., Keeling PWN, et al. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology 1990; 278–83
   PubMed Web of Science ®Google Scholar
• Cremer M., Lambert R., Lamers C. B., Delle Fave G, Maier C. A double-blind study of pantoprazole and ranitidine in the treatment of acute duodenal ulcer: a multicentre trial. Gut 1993, In press
   Google Scholar
• Londong W., Barth H., Dammann H. G., Hengels K. J., Kleinert R., Müller P, et al. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991; 5: 245–54
   PubMed Web of Science ®Google Scholar
• McTavish D, Buckley MM-T, Heel R. C. Omeprazole: an updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991; 42: 138–70
   PubMed Web of Science ®Google Scholar
• Mulder CJJ, Schipper D. L. Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials. Scand J Gastroenterol 1990; 25(Suppl 178)62–6
   Google Scholar